New Launch5 Nov 2025, 09:10 am
Marksans Pharma's UK Subsidiary Gets Marketing Authorisation for Exemestane 25mg Film-Coated Tablets
AI Summary
Marksans Pharma Ltd's wholly owned subsidiary, Relonchem Ltd in the UK, has received Marketing Authorisation for its product Exemestane 25mg film-coated tablets from the UK MHRA. This authorisation is a significant step for Marksans Pharma, demonstrating its commitment to expanding its product portfolio and global reach.
Key Highlights
- Marksans Pharma's UK subsidiary, Relonchem Ltd, receives Marketing Authorisation for Exemestane 25mg film-coated tablets.
- The authorisation is from the UK MHRA.
- This is a significant step for Marksans Pharma in expanding its product portfolio and global reach.